BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diederich NJ, Mcintyre DJ. Sleep disorders in Parkinson's disease: Many causes, few therapeutic options. Journal of the Neurological Sciences 2012;314:12-9. [DOI: 10.1016/j.jns.2011.10.025] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Docu Axelerad A, Stroe AZ, Arghir OC, Docu Axelerad D, Gogu AE. Respiratory Dysfunctions in Parkinson's Disease Patients. Brain Sci 2021;11:595. [PMID: 34064360 DOI: 10.3390/brainsci11050595] [Reference Citation Analysis]
2 Zhou J, Zhang J, Lam SP, Tang X, Wing YK. Clinical Biomarkers of Neurodegeneration in REM Sleep Behavior Disorder. J Sleep Med 2015;12:27-33. [DOI: 10.13078/jsm.15006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Slater G, Steier J. Excessive daytime sleepiness in sleep disorders. J Thorac Dis 2012;4:608-16. [PMID: 23205286 DOI: 10.3978/j.issn.2072-1439.2012.10.07] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
4 Uludag IF, Tiftikcioglu BI, Ertekin C. Spontaneous Swallowing during All-Night Sleep in Patients with Parkinson Disease in Comparison with Healthy Control Subjects. Sleep 2016;39:847-54. [PMID: 26943467 DOI: 10.5665/sleep.5640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Zhou J, Zhang J, Lam SP, Chan JW, Mok V, Chan A, Li SX, Liu Y, Tang X, Yung WH, Wing YK. Excessive Daytime Sleepiness Predicts Neurodegeneration in Idiopathic REM Sleep Behavior Disorder. Sleep 2017;40. [PMID: 28329332 DOI: 10.1093/sleep/zsx041] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
6 Sulaiman NS, Bandick L, Aiyappan V. Signals from an "Alien" Force. Ann Am Thorac Soc 2018;15:760-3. [PMID: 29856251 DOI: 10.1513/AnnalsATS.201712-929CC] [Reference Citation Analysis]
7 Deak MC, Winkelman JW. Insomnia. Neurologic Clinics 2012;30:1045-66. [DOI: 10.1016/j.ncl.2012.08.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
8 Bhattacharya A, Lenka A, Stezin A, Kamble N, Pal PK. Overview of sleep disturbances and their management in Parkinson plus disorders. Journal of the Neurological Sciences 2020;415:116891. [DOI: 10.1016/j.jns.2020.116891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Reynolds GO, Otto MW, Ellis TD, Cronin-Golomb A. The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease. Mov Disord 2016;31:23-38. [PMID: 26715466 DOI: 10.1002/mds.26484] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 10.6] [Reference Citation Analysis]
10 Yang HJ, Kim HJ, Koh SB, Kim JS, Ahn TB, Cheon SM, Cho JW, Kim YJ, Ma HI, Park MY, Baik JS, Lee PH, Chung SJ, Kim JM, Song IU, Kim JY, Sung YH, Kwon DY, Lee JH, Lee JY, Kim JS, Yun JY, Kim HJ, Hong JY, Kim MJ, Youn J, Kim JS, Oh ES, Yoon WT, You S, Kwon KY, Park HE, Lee SY, Kim Y, Kim HT, Kim SJ. Subtypes of Sleep Disturbance in Parkinson's Disease Based on the Cross-Culturally Validated Korean Version of Parkinson's Disease Sleep Scale-2. J Clin Neurol 2020;16:66-74. [PMID: 31942760 DOI: 10.3988/jcn.2020.16.1.66] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Hagenow S, Affini A, Pioli EY, Hinz S, Zhao Y, Porras G, Namasivayam V, Müller CE, Lin JS, Bezard E, Stark H. Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson's Disease. J Med Chem 2021;64:8246-62. [PMID: 34107215 DOI: 10.1021/acs.jmedchem.0c00914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bonnet AM, Jutras MF, Czernecki V, Corvol JC, Vidailhet M. Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinsons Dis 2012;2012:198316. [PMID: 22888466 DOI: 10.1155/2012/198316] [Cited by in Crossref: 32] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
13 Kaminska M, Mery VP, Lafontaine AL, Robinson A, Benedetti A, Gros P, Kimoff RJ. Change in Cognition and Other Non-Motor Symptoms With Obstructive Sleep Apnea Treatment in Parkinson Disease. J Clin Sleep Med 2018;14:819-28. [PMID: 29734988 DOI: 10.5664/jcsm.7114] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
14 Amosova NA, Smolentseva IG, Guseinova PM, Maslyuk OA, Gavrilov EL. [Sleep disorders in the early stage of Parkinson's disease in untreated patients]. Zh Nevrol Psikhiatr Im S S Korsakova 2016;116:77-81. [PMID: 27723714 DOI: 10.17116/jnevro20161166277-81] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
15 Lajoie AC, Lafontaine AL, Kimoff RJ, Kaminska M. Obstructive Sleep Apnea in Neurodegenerative Disorders: Current Evidence in Support of Benefit from Sleep Apnea Treatment. J Clin Med 2020;9:E297. [PMID: 31973065 DOI: 10.3390/jcm9020297] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
16 Figorilli M, Congiu P, Lecca R, Gioi G, Frau R, Puligheddu M. Sleep in Parkinson's Disease with Impulse Control Disorder. Curr Neurol Neurosci Rep 2018;18:68. [PMID: 30099617 DOI: 10.1007/s11910-018-0875-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Yu SY, Sun L, Liu Z, Huang XY, Zuo LJ, Cao CJ, Zhang W, Wang XM. Sleep disorders in Parkinson's disease: clinical features, iron metabolism and related mechanism. PLoS One 2013;8:e82924. [PMID: 24376607 DOI: 10.1371/journal.pone.0082924] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
18 Mao ZJ, Liu CC, Ji SQ, Yang QM, Ye HX, Han HY, Xue Z. Clinical characteristics of sleep disorders in patients with Parkinson's disease. J Huazhong Univ Sci Technolog Med Sci 2017;37:100-4. [PMID: 28224427 DOI: 10.1007/s11596-017-1701-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
19 da Silva-júnior FP, do Prado GF, Barbosa ER, Tufik S, Togeiro SM. Sleep disordered breathing in Parkinson's disease: A critical appraisal. Sleep Medicine Reviews 2014;18:173-8. [DOI: 10.1016/j.smrv.2013.04.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
20 Friedman JH. Announcing a new continuing medical education course: “Bridging Neurology and Psychiatry: Movement Disorders”. Cogn Behav Neurol 2013;26:56-8. [PMID: 23967519 DOI: 10.1097/wnn.0b013e31829af2fb] [Reference Citation Analysis]
21 Priano L, Bigoni M, Albani G, Sellitti L, Giacomotti E, Picconi R, Cremascoli R, Zibetti M, Lopiano L, Mauro A. Sleep microstructure in Parkinson's disease: cycling alternating pattern (CAP) as a sensitive marker of early NREM sleep instability. Sleep Medicine 2019;61:57-62. [DOI: 10.1016/j.sleep.2019.03.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
22 Willison LD, Kudo T, Loh DH, Kuljis D, Colwell CS. Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model. Exp Neurol 2013;243:57-66. [PMID: 23353924 DOI: 10.1016/j.expneurol.2013.01.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
23 Lin F, Su Y, Weng Y, Lin X, Weng H, Cai G, Cai G. The effects of bright light therapy on depression and sleep disturbances in patients with Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. Sleep Med 2021;83:280-9. [PMID: 34052783 DOI: 10.1016/j.sleep.2021.03.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Maiga B, Diop MS, Sangare M, Dembele K, Cisse L, Kone O, Seck LB, Landoure G, Guinto CO, Ndiaye M, Ndiaye MM. Sleep quality assessment in 35 Parkinson's disease patients in the Fann Teaching Hospital, Dakar, Senegal. Rev Neurol (Paris) 2016;172:242-7. [PMID: 26993564 DOI: 10.1016/j.neurol.2015.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
25 Kharkar S, Ellenbogen JR, Samuel M, Rizos A, Silverdale M, Chaudhuri KR, Ashkan K. Changes in Parkinson's disease sleep symptoms and daytime somnolence after bilateral subthalamic deep brain stimulation in Parkinson's disease. NPJ Parkinsons Dis 2018;4:16. [PMID: 29845108 DOI: 10.1038/s41531-018-0053-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 Zhu J, Lu L, Zhong M, Jiang X, Wu Z, Dong J, Pan Y, Zhang L. Increased rapid eye movement density in Chinese patients with Parkinson's disease and RBD. Neurol Sci 2021;42:961-8. [PMID: 32676757 DOI: 10.1007/s10072-020-04597-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Choi JH, Kim JM, Yang HK, Lee HJ, Shin CM, Jeong SJ, Kim WS, Han JW, Yoon IY, Song YS, Bae YJ. Clinical Perspectives of Parkinson's Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists. J Korean Med Sci 2020;35:e230. [PMID: 32686370 DOI: 10.3346/jkms.2020.35.e230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Shen Y, Huang JY, Li J, Liu CF. Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management. Chin Med J (Engl) 2018;131:974-81. [PMID: 29664059 DOI: 10.4103/0366-6999.229889] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
29 Baille G, De Jesus AM, Perez T, Devos D, Dujardin K, Charley CM, Defebvre L, Moreau C. Ventilatory Dysfunction in Parkinson's Disease. J Parkinsons Dis 2016;6:463-71. [PMID: 27314755 DOI: 10.3233/JPD-160804] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 5.2] [Reference Citation Analysis]
30 Loddo G, Calandra-Buonaura G, Sambati L, Giannini G, Cecere A, Cortelli P, Provini F. The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice. Front Neurol 2017;8:42. [PMID: 28261151 DOI: 10.3389/fneur.2017.00042] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 9.2] [Reference Citation Analysis]
31 Zhang X, Xie A. Improvement of Subthalamic Nucleus Deep Brain Stimulation in Sleeping Symptoms in Parkinson's Disease: A Meta-Analysis. Parkinsons Dis 2019;2019:6280896. [PMID: 31687125 DOI: 10.1155/2019/6280896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Dos Santos AB, Barreto GE, Kohlmeier KA. Treatment of sleeping disorders should be considered in clinical management of Parkinson's disease. Front Aging Neurosci 2014;6:273. [PMID: 25346687 DOI: 10.3389/fnagi.2014.00273] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
33 Suzuki K, Miyamoto M, Miyamoto T, Hirata K. Parkinson's disease and sleep/wake disturbances. Curr Neurol Neurosci Rep 2015;15:8. [PMID: 25687697 DOI: 10.1007/s11910-015-0525-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
34 Kim HJ, Jeon B. How close are we to individualized medicine for Parkinson's disease? Expert Rev Neurother 2016;16:815-30. [PMID: 27105072 DOI: 10.1080/14737175.2016.1182021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
35 Xiang YQ, Xu Q, Sun QY, Wang ZQ, Tian Y, Fang LJ, Yang Y, Tan JQ, Yan XX, Tang BS, Guo JF. Clinical Features and Correlates of Excessive Daytime Sleepiness in Parkinson's Disease. Front Neurol 2019;10:121. [PMID: 30837940 DOI: 10.3389/fneur.2019.00121] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
36 Barkhuizen M, Anderson DG, Grobler AF. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies. Neurochem Int 2016;93:6-25. [PMID: 26743617 DOI: 10.1016/j.neuint.2015.12.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
37 Ratti PL, Nègre-Pagès L, Pérez-Lloret S, Manni R, Damier P, Tison F, Destée A, Rascol O. Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort. Parkinsonism Relat Disord 2015;21:1323-9. [PMID: 26411501 DOI: 10.1016/j.parkreldis.2015.09.025] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
38 Rosa-grilo M, Qamar MA, Evans A, Chaudhuri KR. The efficacy of apomorphine – A non-motor perspective. Parkinsonism & Related Disorders 2016;33:S28-35. [DOI: 10.1016/j.parkreldis.2016.11.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
39 Akbar U, Friedman JH. Recognition and treatment of neuropsychiatric disturbances in Parkinson's disease. Expert Rev Neurother 2015;15:1053-65. [PMID: 26289491 DOI: 10.1586/14737175.2015.1077703] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
40 Jankovic J, Poewe W. Therapies in Parkinsonʼs disease: . Current Opinion in Neurology 2012;25:433-47. [DOI: 10.1097/wco.0b013e3283542fc2] [Cited by in Crossref: 113] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
41 Schneider SA, Obeso JA. Clinical and pathological features of Parkinson's disease. Curr Top Behav Neurosci 2015;22:205-20. [PMID: 24850081 DOI: 10.1007/7854_2014_317] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 7.4] [Reference Citation Analysis]
42 Wang F, Sun L, Zhang XZ, Jia J, Liu Z, Huang XY, Yu SY, Zuo LJ, Cao CJ, Wang XM, Zhang W. Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson's Disease. Evid Based Complement Alternat Med 2015;2015:692795. [PMID: 26351515 DOI: 10.1155/2015/692795] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
43 Patel S, Ojo O, Genc G, Oravivattanakul S, Huo Y, Rasameesoraj T, Wang L, Bena J, Drerup M, Foldvary-Schaefer N, Ahmed A, Fernandez HH. A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease (ACCORD-PD). J Clin Mov Disord 2017;4:16. [PMID: 28852567 DOI: 10.1186/s40734-017-0062-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
44 Targa AD, Rodrigues LS, Noseda ACD, Aurich MF, Andersen ML, Tufik S, da Cunha C, Lima MM. Unraveling a new circuitry for sleep regulation in Parkinson's disease. Neuropharmacology 2016;108:161-71. [DOI: 10.1016/j.neuropharm.2016.04.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
45 Prudon B, Duncan GW, Khoo TK, Yarnall AJ, Burn DJ, Anderson KN. Primary sleep disorder prevalence in patients with newly diagnosed Parkinson's disease: Newly Diagnosed PD Sleep Characteristics. Mov Disord 2014;29:259-62. [DOI: 10.1002/mds.25730] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
46 Junho BT, Kummer A, Cardoso FE, Teixeira AL, Rocha NP. Sleep quality is associated with the severity of clinical symptoms in Parkinson's disease. Acta Neurol Belg 2018;118:85-91. [PMID: 29210000 DOI: 10.1007/s13760-017-0868-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]